Evidence map›Paper›PMID 35739227›Full record

ArticleScientific reports2022

Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.

Lang Li, Qiusheng Guo, Gaochen Lan, Fei Liu, Wenwu Wang, Xianmei Lv

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. HENMT1: an RNA methyltransferase in biology and disease.Journal of Zhejiang University. Science. B · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Lang Li *Department of Hematology, Jinhua Hospital of Traditional Chinese Medicine, 439 West Shuangxi Road, Jinhua, 321017, China.
Qiusheng Guo *The Second Clinical Medical College, Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, 310005, China.
Gaochen Lan *Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, 950 Donghai Street, Quanzhou, 362000, China.
Fei LiuDepartment of Dermatology, Jinhua People's Hospital, 267 Danxi East Road, Jinhua, 321000, China.
Wenwu WangDepartment of Oncology, The Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, 363 Guobin Avenue, Fuzhou, 350108, China.
Xianmei LvDepartment of Oncology, Quzhou Kecheng Hospital, 172 Shuanggang Road, Quzhou, 324000, China. 201911011511059@zcmu.edu.cn.
Fujian University of Traditional Chinese Medicine · CNJinhua Academy of Agricultural Sciences · CNQuzhou City People's Hospital · CNSecond Affiliated Hospital of Fujian Medical University · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) tumorigenesis involves a combination of multiple genetic alteration processes. Constructing a survival-associated competing endogenous RNA (ceRNA) network and a multi-mRNA-based prognostic signature model can help us better understand the complexity and genetic characteristics of CESC. In this study, the RNA-seq data and clinical information of CESC patients were downloaded from The Cancer Genome Atlas. Differentially expressed mRNAs, lncRNAs and miRNAs were identified with the edgeR R package. A four-mRNA prognostic signature was developed by multivariate Cox regression analysis. Kaplan-Meier survival with the log-rank tests was performed to assess survival rates. The relationships between overall survival (OS) and clinical parameters were evaluated by Cox regression analysis. A survival-associated ceRNA network was constructed with the multiMiR package and miRcode database. Kyoto encyclopedia of genes and genomes (KEGG) analysis and gene ontology analyses were used to identify the functional role of the ceRNA network in the prognosis of CESC. A total of 298 differentially expressed mRNAs, 8 miRNAs, and 29 lncRNAs were significantly associated with the prognosis of CESC. A prognostic signature model based on 4 mRNAs (OPN3, DAAM2, HENMT1, and CAVIN3) was developed, and the prognostic ability of this signature was indicated by the AUC of 0.726. Patients in the high-risk group exhibited significantly worse OS. The KEGG pathways, TGF-β and Cell adhesion molecules, were significantly enriched. In this study, a CESC-associated ceRNA network was constructed, and a multi-mRNA-based prognostic model for CESC was developed based on the ceRNA network, providing a new perspective for cancer pathogenesis research.

Indexed as

MicroRNAsRNA, Long NoncodingUterine Cervical NeoplasmsFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansKaplan-Meier EstimatePrognosisRNA, MessengerRod OpsinsMicroRNAsOPN3 protein, humanRNA, Long NoncodingRNA, MessengerRod Opsins

Identifiers

PMID35739227
PMCPMC9226135
OpenAlexW4283368241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.